Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

Liver disease is a growing health concern in the United States, affecting millions of adults. One of the most common types is ...

A dual transcription factor activation method enables rapid generation of vascular organoids, accelerating modeling and therapy development.

Eating foods to support healthy hair doesn’t have to mean overhauling your entire diet. In fact, many of the best foods for ...

ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, ...

Skeletal Muscle, Piceatannol, Energy Metabolism, SIRT1, Mitochondria Share and Cite: Tsuda, H. , Uchida, T. , Okuno, S. , ...

Cells and processes that bring about the effect of immunotherapy on atopic dermatitis have been revealed. A research team led by Park Chang-wook, a dermatologist at Severance Hospital, Park Jung-won, ...

Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly diagnosed mNPM1 and KMT2Ar AML patients – – Promising clinical activity and deep responses observed ...

Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy-evaluable pivotal R/R mNPM1 AML population – – 60% (3/5) ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...